Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment

Bian-Rong Wang,1 Hui-Fen Zheng,1 Chang Xu,1 Yi Sun,1 Ying-Dong Zhang,2 Jian-Quan Shi2 1Department of Neurology, Geriatric Hospital of Nanjing Medical University, Nanjing, Jiangsu Province 210024, People’s Republic of China; 2Department of Neurology, Nanjing First Hospital, Nanjing Medical...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang BR, Zheng HF, Xu C, Sun Y, Zhang YD, Shi JQ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/703612f6ce8b489a82351d312407efb1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:703612f6ce8b489a82351d312407efb1
record_format dspace
spelling oai:doaj.org-article:703612f6ce8b489a82351d312407efb12021-12-02T07:27:25ZComparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment1178-2021https://doaj.org/article/703612f6ce8b489a82351d312407efb12019-09-01T00:00:00Zhttps://www.dovepress.com/comparative-diagnostic-accuracy-of-ace-iii-and-moca-for-detecting-mild-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Bian-Rong Wang,1 Hui-Fen Zheng,1 Chang Xu,1 Yi Sun,1 Ying-Dong Zhang,2 Jian-Quan Shi2 1Department of Neurology, Geriatric Hospital of Nanjing Medical University, Nanjing, Jiangsu Province 210024, People’s Republic of China; 2Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province 210006, People’s Republic of ChinaCorrespondence: Ying-Dong Zhang; Jian-Quan ShiDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, No. 68, Changle Road, Nanjing, Jiangsu Province 210006, People’s Republic of ChinaTel +86 0 258 772 6218; +86 0 258 772 6224Email zhangyingdong@aliyun.com; myxiyi_0717@163.comObjective: The aim of this study was to validate the reliability of the Chinese version of Addenbrooke’s Cognitive Examination III (ACE-III) for detecting mild cognitive impairment. Furthermore, the present study compares the diagnostic accuracy of ACE-III with that of Montreal Cognitive Assessment (MoCA).Methods: One hundred and twenty patients with MCI and 136 healthy controls were included in the study. All patients were evaluated by the Chinese version of ACE-III, MoCA and MMSE.Results: Subjects in the control group showed better performance in ACE-III total score and its subdomain scores than those in the MCI group. There was a significantly positive correlation between ACE-III total score and MoCA score. Meanwhile, there was also a significantly positive correlation between ACE-III total score and MMSE score. For ACE-III total score, a cut-off point of 85 yielded a sensitivity of 97.3% and a specificity of 90.7%. The AUC for ACE-III total score was 0.978. For MoCA, a cut-off point of 23 yielded a sensitivity of 86.5% and a specificity of 97.7%. The AUC for MoCA was 0.961. There were no significant differences in diagnostic accuracy between ACE-III and MoCA.Conclusion: The present findings support that both ACE-III and MoCA are useful for detecting MCI in early stages.Keywords: Addenbrooke’s Cognitive Examination III, Montreal Cognitive Assessment, mild cognitive impairment, cognitive screening, Chinese  Wang BRZheng HFXu CSun YZhang YDShi JQDove Medical PressarticleAddenbrooke’s Cognitive Examination IIIMontreal Cognitive AssessmentMild cognitive impairmentCognitive screeningChineseNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 15, Pp 2647-2653 (2019)
institution DOAJ
collection DOAJ
language EN
topic Addenbrooke’s Cognitive Examination III
Montreal Cognitive Assessment
Mild cognitive impairment
Cognitive screening
Chinese
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Addenbrooke’s Cognitive Examination III
Montreal Cognitive Assessment
Mild cognitive impairment
Cognitive screening
Chinese
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Wang BR
Zheng HF
Xu C
Sun Y
Zhang YD
Shi JQ
Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment
description Bian-Rong Wang,1 Hui-Fen Zheng,1 Chang Xu,1 Yi Sun,1 Ying-Dong Zhang,2 Jian-Quan Shi2 1Department of Neurology, Geriatric Hospital of Nanjing Medical University, Nanjing, Jiangsu Province 210024, People’s Republic of China; 2Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province 210006, People’s Republic of ChinaCorrespondence: Ying-Dong Zhang; Jian-Quan ShiDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, No. 68, Changle Road, Nanjing, Jiangsu Province 210006, People’s Republic of ChinaTel +86 0 258 772 6218; +86 0 258 772 6224Email zhangyingdong@aliyun.com; myxiyi_0717@163.comObjective: The aim of this study was to validate the reliability of the Chinese version of Addenbrooke’s Cognitive Examination III (ACE-III) for detecting mild cognitive impairment. Furthermore, the present study compares the diagnostic accuracy of ACE-III with that of Montreal Cognitive Assessment (MoCA).Methods: One hundred and twenty patients with MCI and 136 healthy controls were included in the study. All patients were evaluated by the Chinese version of ACE-III, MoCA and MMSE.Results: Subjects in the control group showed better performance in ACE-III total score and its subdomain scores than those in the MCI group. There was a significantly positive correlation between ACE-III total score and MoCA score. Meanwhile, there was also a significantly positive correlation between ACE-III total score and MMSE score. For ACE-III total score, a cut-off point of 85 yielded a sensitivity of 97.3% and a specificity of 90.7%. The AUC for ACE-III total score was 0.978. For MoCA, a cut-off point of 23 yielded a sensitivity of 86.5% and a specificity of 97.7%. The AUC for MoCA was 0.961. There were no significant differences in diagnostic accuracy between ACE-III and MoCA.Conclusion: The present findings support that both ACE-III and MoCA are useful for detecting MCI in early stages.Keywords: Addenbrooke’s Cognitive Examination III, Montreal Cognitive Assessment, mild cognitive impairment, cognitive screening, Chinese  
format article
author Wang BR
Zheng HF
Xu C
Sun Y
Zhang YD
Shi JQ
author_facet Wang BR
Zheng HF
Xu C
Sun Y
Zhang YD
Shi JQ
author_sort Wang BR
title Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment
title_short Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment
title_full Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment
title_fullStr Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment
title_full_unstemmed Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment
title_sort comparative diagnostic accuracy of ace-iii and moca for detecting mild cognitive impairment
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/703612f6ce8b489a82351d312407efb1
work_keys_str_mv AT wangbr comparativediagnosticaccuracyofaceiiiandmocafordetectingmildcognitiveimpairment
AT zhenghf comparativediagnosticaccuracyofaceiiiandmocafordetectingmildcognitiveimpairment
AT xuc comparativediagnosticaccuracyofaceiiiandmocafordetectingmildcognitiveimpairment
AT suny comparativediagnosticaccuracyofaceiiiandmocafordetectingmildcognitiveimpairment
AT zhangyd comparativediagnosticaccuracyofaceiiiandmocafordetectingmildcognitiveimpairment
AT shijq comparativediagnosticaccuracyofaceiiiandmocafordetectingmildcognitiveimpairment
_version_ 1718399407685107712